{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:11:19Z","timestamp":1793412679113,"version":"4.5.0"},"reference-count":59,"publisher":"Informa UK Limited","issue":"12","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300752"],"award-info":[{"award-number":["81300752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jilin Province Science and Technology Development Plan Project","award":["20200201333JC"],"award-info":[{"award-number":["20200201333JC"]}]},{"name":"Changchun Science and Technology Development Plan Project","award":["21ZGM19"],"award-info":[{"award-number":["21ZGM19"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.2217\/imt-2021-0303","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T09:06:50Z","timestamp":1655111210000},"page":"985-994","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Indications and Effects of Biological Agents in the Treatment of Noninfectious Uveitis"],"prefix":"10.1080","volume":"14","author":[{"given":"Bowen","family":"Li","sequence":"first","affiliation":[{"name":"Ophthalmologic Center of the Second Hospital, Jilin University, Ziqiang Street 218, Changchun, 130000, P.R. China"},{"name":"Clinical College, Jilin University, Xinmin Street 70, Changchun, 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Ophthalmologic Center of the Second Hospital, Jilin University, Ziqiang Street 218, Changchun, 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Bai","sequence":"additional","affiliation":[{"name":"Ophthalmologic Center of the Second Hospital, Jilin University, Ziqiang Street 218, Changchun, 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bainan","family":"Tong","sequence":"additional","affiliation":[{"name":"Ophthalmologic Center of the Second Hospital, Jilin University, Ziqiang Street 218, Changchun, 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-1872","authenticated-orcid":false,"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[{"name":"Ophthalmologic Center of the Second Hospital, Jilin University, Ziqiang Street 218, Changchun, 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.02.019"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2011.06.005"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-1793"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.12.007"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.134"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2018.16"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20904"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez449"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171006"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41026"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.12304"},{"issue":"4","key":"e_1_3_2_14_1","first-page":"680","article-title":"Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis","volume":"37","author":"Tosi GM","year":"2019","unstructured":"Tosi GM , SotaJ , VitaleAet al. Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. Clin. Exp. Rheumatol.37(4), 680\u2013683 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"e_1_3_2_15_1","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana N","year":"2018","unstructured":"Palmou-Fontana N , Calvo-R\u00edoV , Mart\u00edn-VarillasJLet al. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. Clin. Exp. Rheumatol.36(4), 652\u2013657 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1351573"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0181-5512(05)81044-7"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1349-x"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-009-0691-6"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep41744"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19758"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0419-z"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283641ede"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.08.010"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1421233"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102152"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-020-00759-1"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160064"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.115"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S265812"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520969494"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1729736"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1803063"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1730326"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.06.022"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.014"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000619"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz167"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1324-x"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.12.009"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0125"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.03.001"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1606256"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319847881"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-00215-1"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000336188"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0265-9"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0118-2"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2010.2729"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.764067"},{"key":"e_1_3_2_51_1","first-page":"641","article-title":"Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells","volume":"26","author":"Bing SJ","year":"2020","unstructured":"Bing SJ , LyuC , XuBet al. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells. Mol. Vis.26, 641\u2013651 (2020).","journal-title":"Mol. Vis."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615977"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0178"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key287"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019839650"},{"issue":"1","key":"e_1_3_2_56_1","first-page":"15","article-title":"Selective JAKinibs: prospects in inflammatory and autoimmune diseases","volume":"33","author":"Virtanen AT","year":"2019","unstructured":"Virtanen AT , HaikarainenT , RaivolaJ , SilvennoinenO. Selective JAKinibs: prospects in inflammatory and autoimmune diseases. Bio. Drugs33(1), 15\u201332 (2019).","journal-title":"Bio. Drugs"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04875-w"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05651-5"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.3789"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.07.028"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160716414"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2021-0303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:53:04Z","timestamp":1715997184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2021-0303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.2217\/imt-2021-0303"],"URL":"https:\/\/doi.org\/10.2217\/imt-2021-0303","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}